Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNA-seq on NUT Carcinoma (NC) cell lines treated with DMSO, Panobinostat or IRBM6
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
NUT Carcinoma
PubMed Full text in PMC Similar studies
ChIP-seq analysis of BRD4-NUT and H3K27ac distribution in NUT Carcinoma cell line TC-797 treated with DMSO or Panobinostat
PubMed Full text in PMC Similar studies SRA Run Selector
A genetically engineered mouse model of NUT carcinoma
A genetically engineered mouse model of NUT carcinoma (CUT&RUN)
A genetically engineered mouse model (GEMM) of NUT carcinoma (RNA-Seq)
Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734
Chromatin-associated protein interactions drive megadomain formation in NUT midline carcinoma
Cell state-dependent chromatin targeting in NUT carcinoma
Effect of EZH2 inhibition on NUT carcinoma gene expression over time
PubMed Full text in PMC Similar studies Analyze with GEO2R
CUT&RUN profiling of histone H3K27ac and H3K27me3 localization after pharmacological inhibition of EZH2 and BET proteins
Effect of EZH2 and BET bromodomain inhibition, alone and combined, on NUT carcinoma gene expression
Recovery and analysis of nascent RNA
Chip-seq mapping of active chromatin marks in BRD4-NUT and different NMC cells
Chip-seq BRD4NUT-BioTAP mapping in 293Trex and 797 cells
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains
Genes altered by miR-766-5p in two cancer cell lines
PubMed Similar studies Analyze with GEO2R
Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo [RNA-seq]
Differentiation of NUT midline carcinoma by epigenomic reprogramming
HDAC inhibitors result in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodies
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on